US EditionRo to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
- Ro is working to make weight loss drug Zepbound more affordable
- The collaboration with Eli Lilly aims to achieve this goal
- Ro and Eli Lilly focus on offering lower-price vials
11 Articles
11 Articles
The drug class surpassed traditional areas of medicine, such as oncology and immunology Drugs used for weight loss, such as ozempic, Wegovy, Mounjaro and Zepbound, contributed to the growth of the pharmaceutical industry this year, according to the report “The weight is over: How GLP-1 treatments are reshaping pharma and beyond” (The burden is over: how GLP-1 treatments are reshaping the pharmaceutical industry and much more, in free translation…
Eli Lilly will start offering vials of her best-selling weight loss drug, Zepbound, through Ro's telehealth platform this Wednesday, providing patients with another way to access a more affordable version of the injection. Previously, patients could only get vials of Zepbound, which are normally sold in a self-injecting pen, through Lilly's direct-sell site to Lilly's consumer, LillyDirect. To reinforce the supplies of popular drugs amid a natio…
Eli Lilly is partnering with Ro to make it easier than ever to get Zepbound
Eli Lilly (LLY) has announced it will make lower-priced, single-dose vials of its popular weight-loss treatment Zepound available on telehealth platform Ro. Starting today, consumers can get an online diagnosis, prescription services, and Zepbound vials delivered to straight their homes — all via Ro.Read more...
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
